Thorasys Thoracic Medical Systems Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Thorasys Thoracic Medical Systems Inc. - overview
Established
2007
Location
Montreal, QC-Quebec, Canada
Primary Industry
Medical Devices & Equipment
About
Thorasys Thoracic Medical Systems Inc. develops innovative pulmonary function testing devices and software. Their primary focus is improving respiratory assessments for healthcare professionals through advanced technology solutions. Thorasys Thoracic Medical Systems Inc.
specializes in developing pulmonary function testing devices. Incorporated in 2007, the company is headquartered in Montreal, Canada. Thomas Schuessler founded the firm, which has successfully completed a total of 4 deals, with the most recent funding round taking place on April 26, 2022. The company raised USD 1.
30 mn in funding from Anges Quebec, bringing the total amount raised to USD 1. 30 mn. Thorasys specializes in pulmonary function testing devices and software, notably the tremoflo® C-100 Airwave Oscillometry System™. This compact device provides quantitative assessments of airway function, utilizing oscillometric principles for accurate measurements.
The user-friendly software guides operators through data collection, serving healthcare professionals such as pulmonologists and respiratory therapists. Thorasys markets its products primarily in North America and Europe, aiming to enhance global respiratory care. Revenue generation for Thorasys is structured through direct sales of the tremoflo® C-100 and its accompanying software. The company engages in B2B transactions directly with healthcare institutions, offering competitive pricing plans tailored to budgets.
Service agreements and software maintenance options ensure ongoing relationships with clients, supporting sustained revenue through equipment sales and support services. In April 2022, Thorasys Thoracic Medical Systems Inc. raised USD 1. 30 mn in venture funding from BDC Capital.
The company intends to leverage these funds to develop new products and expand its presence in international markets. Specific markets targeted for expansion include ongoing efforts to penetrate additional regions within Europe and North America, with plans to enhance product offerings in the coming years.
Current Investors
Anges Quebec, Atlantic Canada Opportunities Agency, Invest Nova Scotia
Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic, Medical & Imaging Laboratories, Epidemiology, Medical Devices & Equipment
Website
www.thorasys.com
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Thorasys Thoracic Medical Systems Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Unspecified Round | Completed | Thorasys Thoracic Medical Systems Inc. | - | ||||||||
| Unspecified Round | Completed | Thorasys Thoracic Medical Systems Inc. | - | ||||||||
| Unspecified Round | Completed | Thorasys Thoracic Medical Systems Inc. | - | ||||||||
| Seed | Completed | Thorasys Thoracic Medical Systems Inc. | - |
Displaying 1 - 4 of 4
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.